{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:24:10Z","timestamp":1768422250858,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,9]],"date-time":"2026-12-09T00:00:00Z","timestamp":1796774400000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["21KK0279"],"award-info":[{"award-number":["21KK0279"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejpb.2025.114955","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:08:16Z","timestamp":1764922096000},"page":"114955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["One-step formation of plasmid DNA\u2013loaded lipid\u2013inorganic salt nanoparticles optimized via two-step design of experiments"],"prefix":"10.1016","volume":"219","author":[{"given":"Riku","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2218-4547","authenticated-orcid":false,"given":"Shintaro","family":"Fumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Muttil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9484-6889","authenticated-orcid":false,"given":"Kazuya","family":"Okami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5980-5849","authenticated-orcid":false,"given":"Hayato","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-9541","authenticated-orcid":false,"given":"Hirotaka","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7191-8918","authenticated-orcid":false,"given":"Koyo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114955_b0005","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/ph16101416","article-title":"Current State of Human Gene Therapy: Approved Products and Vectors","volume":"16","author":"Shchaslyvyi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2025.114955_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/life13040903","article-title":"Non-Viral Carriers for Nucleic Acids delivery: Fundamentals and Current Applications","volume":"13","author":"Shtykalova","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ejpb.2025.114955_b0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.11.041","article-title":"Gene therapy and DNA delivery systems","volume":"459","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114955_b0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41587-019-0402-x","article-title":"Emerging patent landscape for non-viral vectors used for gene therapy","volume":"38","author":"Pican\u00e7o-Castro","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114955_b0025","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/ijms24043375","article-title":"Research Status and Prospect of Non-Viral Vectors based on siRNA: a Review","volume":"24","author":"Tong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114955_b0030","article-title":"Is Viral Vector Gene Delivery More Effective Using Biomaterials?","volume":"10","author":"Wang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2025.114955_b0035","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.3390\/ijms22147545","article-title":"How far are non\u2010viral vectors to come of age and reach clinical translation in gene therapy?","volume":"22","author":"Sainz-Ramos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114955_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biotech11010006","article-title":"Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer","volume":"11","author":"Kanvinde","year":"2022","journal-title":"Biotech"},{"key":"10.1016\/j.ejpb.2025.114955_b0045","article-title":"Non Viral Vectors in Gene Therapy- An Overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagnostic Res."},{"key":"10.1016\/j.ejpb.2025.114955_b0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg1577","article-title":"Towards safe, non-viral therapeutic gene expression in humans","volume":"6","author":"Glover","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2025.114955_b0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral Gene Delivery: Principle, Limitations, and Recent Progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114955_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2004.11.015","article-title":"Drug-incorporating calcium carbonate nanoparticles for a new delivery system","volume":"103","author":"Ueno","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0065","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.3390\/ijms21186721","article-title":"Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells","volume":"21","author":"Haque","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114955_b0070","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1021\/nn4012384","article-title":"A Highly Efficient Synthetic Vector: Non-Hydrodynamic Delivery of DNA to Hepatocyte Nuclei In Vivo","volume":"7","author":"Hu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114955_b0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/1061186X.2017.1315687","article-title":"One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin","volume":"25","author":"Peng","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2025.114955_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2019.03.021","article-title":"Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles","volume":"302","author":"Peng","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/nn506210a","article-title":"PH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers","volume":"9","author":"Min","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114955_b0090","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1098\/rstb.2004.1500","article-title":"Protein structure, stability and solubility in water and other solvents","volume":"359","author":"Pace","year":"2004","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.ejpb.2025.114955_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2144\/btn-2019-0109","article-title":"A Systematic Investigation of Key Factors of Nucleic Acid Precipitation Toward Optimized DNA\/RNA Isolation","volume":"68","author":"Li","year":"2020","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejpb.2025.114955_b0100","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/cells13141183","article-title":"One-step Formation Method of Plasmid DNA-Loaded, Extracellular Vesicles-Mimicking Lipid Nanoparticles Based on Nucleic Acids Dilution-Induced Assembly","volume":"13","author":"Okami","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejpb.2025.114955_b0105","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2025.114955_b0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jconrel.2020.08.031","article-title":"The use of design of experiments with multiple responses to determine optimal formulations for in vivo hepatic mRNA delivery","volume":"327","author":"Hashiba","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0115","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1248\/cpb.c19-00553","article-title":"The Usefulness of Definitive Screening Design for a Quality by Design Approach as Demonstrated by a Pharmaceutical Study of Orally Disintegrating Tablet","volume":"67","author":"Takagaki","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2025.114955_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/bbrc.1998.9602","article-title":"Asialoglycoprotein Receptor-Mediated Gene transfer using Novel Galactosylated Cationic Liposomes","volume":"252","author":"Kawakami","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2025.114955_b0125","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1021\/bi00663a008","article-title":"2-Imino-2-methoxyethyl 1-Thioglycosides: New Reagents for Attaching Sugars to Proteins","volume":"15","author":"Lee","year":"1976","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2025.114955_b0130","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/biom14121558","article-title":"Lipid Nanoparticles Enable Efficient In Vivo DNA Knock-In via HITI-Mediated Genome Editing","volume":"14","author":"Hirose","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2025.114955_b0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.colsurfb.2014.03.007","article-title":"Modification of nanostructured calcium carbonate for efficient gene delivery","volume":"118","author":"Zhao","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ejpb.2025.114955_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114955_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206968","article-title":"Biodegradable Cationic and Ionizable Cationic Lipids:A Roadmap for Safer Pharmaceutical Excipients","volume":"19","author":"J\u00f6rgensen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2025.114955_b0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: Current perspectives","volume":"154\u2013155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114955_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejpb.2025.114955_b0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpharm.2011.11.036","article-title":"A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale","volume":"423","author":"Xu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114955_b0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2010.03.012","article-title":"Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery","volume":"392","author":"Zhou","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114955_b0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","article-title":"Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor","volume":"158","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2009.11.008","article-title":"Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery","volume":"142","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114955_b0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.canlet.2012.07.011","article-title":"Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles","volume":"334","author":"Kim","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2025.114955_b0195","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/ncomms3763","article-title":"A Ca2+-dependent signalling circuit regulates influenza A virus internalization and infection","volume":"4","author":"Fujioka","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2025.114955_b0200","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2025.114955_b0205","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid\u2013polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114955_b0210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/10717544.2022.2069878","article-title":"Merits and advances of microfluidics in the pharmaceutical field: design technologies and future prospects","volume":"29","author":"Maged","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114955_b0215","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","article-title":"Lipid-based Nanoparticles for Nucleic Acid delivery","volume":"24","author":"Li","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114955_b0220","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/gt.2008.60","article-title":"The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer","volume":"15","author":"Wisse","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejpb.2025.114955_b0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2010.090136","article-title":"The Role of Liver Sinusoidal Cells in Hepatocyte-Directed Gene transfer","volume":"176","author":"Jacobs","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:38:54Z","timestamp":1768390734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S0939641125003339"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114955","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-step formation of plasmid DNA\u2013loaded lipid\u2013inorganic salt nanoparticles optimized via two-step design of experiments","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114955"}}